Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
6.33 +0.04 / +0.64%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.40 +0.07 / +1.11%
 
Volume: 484.5K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$774.7M

Company Description

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of pharmaceutical product candidates for the treatment of obesity. Its product candidate, NB32, is an investigational medicine for weight loss and the maintenance of weight loss; and Empatic used for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Contact Information

Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court
La Jolla California 92037
P:(858) 875-8600
Investor Relations:
(858) 875-8629

Employees

Shareholders

Mutual fund holders46.11%
Other institutional33.05%
Individual stakeholders19.70%

Top Executives

Michael A. NarachiPresident, Chief Executive Officer & Director
Joseph P. HaganCFO, Treasurer & Chief Business Officer
Heather D. TurnerSecretary, Senior Vice President & General Counsel
Preston S. KlassenSenior Vice President & Head-Global Development
Dawn ViveashSenior VP & Head-Global Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.